A citation-based method for searching scientific literature

Alexandra Shields, Caryn Lerman, Patrick Sullivan. Nicotine Tob Res 2004
Times Cited: 31







List of co-cited articles
322 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


The functional mu opioid receptor (OPRM1) Asn40Asp variant predicts short-term response to nicotine replacement therapy in a clinical trial.
C Lerman, E P Wileyto, F Patterson, M Rukstalis, J Audrain-McGovern, S Restine, P G Shields, V Kaufmann, D Redden, N Benowitz,[...]. Pharmacogenomics J 2004
140
41

Barriers to translating emerging genetic research on smoking into clinical practice. Perspectives of primary care physicians.
Alexandra E Shields, David Blumenthal, Kevin B Weiss, Catherine B Comstock, Douglas Currivan, Caryn Lerman. J Gen Intern Med 2005
51
41

Genetic variation in dopaminergic pathways and short-term effectiveness of the nicotine patch.
Elaine C Johnstone, Patricia L Yudkin, Kate Hey, Sarah J Roberts, Sarah J Welch, Michael F Murphy, Siân E Griffiths, Robert T Walton. Pharmacogenetics 2004
110
32

Effectiveness of nicotine patches in relation to genotype in women versus men: randomised controlled trial.
Patricia Yudkin, Marcus Munafò, Kate Hey, Sarah Roberts, Sarah Welch, Elaine Johnstone, Michael Murphy, Siân Griffiths, Robert Walton. BMJ 2004
93
32

The use of race variables in genetic studies of complex traits and the goal of reducing health disparities: a transdisciplinary perspective.
Alexandra E Shields, Michael Fortun, Evelynn M Hammonds, Patricia A King, Caryn Lerman, Rayna Rapp, Patrick F Sullivan. Am Psychol 2005
98
32

Effects of dopamine transporter and receptor polymorphisms on smoking cessation in a bupropion clinical trial.
Caryn Lerman, Peter G Shields, E Paul Wileyto, Janet Audrain, Larry H Hawk, Angela Pinto, Susan Kucharski, Shiva Krishnan, Ray Niaura, Leonard H Epstein. Health Psychol 2003
118
29

Pharmacogenetic investigation of smoking cessation treatment.
Caryn Lerman, Peter G Shields, E Paul Wileyto, Janet Audrain, Angela Pinto, Larry Hawk, Shiva Krishnan, Ray Niaura, Leonard Epstein. Pharmacogenetics 2002
134
29

Impact of CYP2A6 genotype on pretreatment smoking behaviour and nicotine levels from and usage of nicotine replacement therapy.
V Malaiyandi, C Lerman, N L Benowitz, C Jepson, F Patterson, R F Tyndale. Mol Psychiatry 2006
136
29

Nicotine metabolite ratio predicts efficacy of transdermal nicotine for smoking cessation.
Caryn Lerman, Rachel Tyndale, Freda Patterson, E Paul Wileyto, Peter G Shields, Angela Pinto, Neal Benowitz. Clin Pharmacol Ther 2006
199
29

CYP2B6 genotype alters abstinence rates in a bupropion smoking cessation trial.
Anna M Lee, Christopher Jepson, Ewa Hoffmann, Leonard Epstein, Larry W Hawk, Caryn Lerman, Rachel F Tyndale. Biol Psychiatry 2007
95
29

Evidence suggesting the role of specific genetic factors in cigarette smoking.
C Lerman, N E Caporaso, J Audrain, D Main, E D Bowman, B Lockshin, N R Boyd, P G Shields. Health Psychol 1999
237
25

Role of functional genetic variation in the dopamine D2 receptor (DRD2) in response to bupropion and nicotine replacement therapy for tobacco dependence: results of two randomized clinical trials.
Caryn Lerman, Christopher Jepson, E Paul Wileyto, Leonard H Epstein, Margaret Rukstalis, Freda Patterson, Vyga Kaufmann, Stephanie Restine, Larry Hawk, Ray Niaura,[...]. Neuropsychopharmacology 2006
147
25

Case-control study of the D2 dopamine receptor gene and smoking status in lung cancer patients.
M R Spitz, H Shi, F Yang, K S Hudmon, H Jiang, R M Chamberlain, C I Amos, Y Wan, P Cinciripini, W K Hong,[...]. J Natl Cancer Inst 1998
194
22

The effects of the DRD2 polymorphism on smoking cessation and negative affect: evidence for a pharmacogenetic effect on mood.
Paul Cinciripini, David Wetter, Gail Tomlinson, Janice Tsoh, Carl De Moor, Lynn Cinciripini, John Minna. Nicotine Tob Res 2004
59
22

Pharmacogenetics and nicotine addiction treatment.
Marcus R Munafò, Alexandra E Shields, Wade H Berrettini, Freda Patterson, Caryn Lerman. Pharmacogenomics 2005
48
22


Does the DRD2-Taq1 A polymorphism influence treatment response to bupropion hydrochloride for reduction of the nicotine withdrawal syndrome?
Sean P David, Raymond Niaura, George D Papandonatos, William G Shadel, Gary J Burkholder, Dana M Britt, Amy Day, Jeffrey Stumpff, Kent Hutchison, Michael Murphy,[...]. Nicotine Tob Res 2003
44
19


Individualizing nicotine replacement therapy for the treatment of tobacco dependence: a randomized trial.
Caryn Lerman, Vyga Kaufmann, Margaret Rukstalis, Freda Patterson, Kenneth Perkins, Janet Audrain-McGovern, Neal Benowitz. Ann Intern Med 2004
91
19

D2 dopamine receptor gene (DRD2) Taq1 A polymorphism: reduced dopamine D2 receptor binding in the human striatum associated with the A1 allele.
J Thompson, N Thomas, A Singleton, M Piggott, S Lloyd, E K Perry, C M Morris, R H Perry, I N Ferrier, J A Court. Pharmacogenetics 1997
429
19

The genetic epidemiology of smoking.
P F Sullivan, K S Kendler. Nicotine Tob Res 1999
265
19

US physicians' attitudes toward genetic testing for cancer susceptibility.
A N Freedman, L Wideroff, L Olson, W Davis, C Klabunde, K P Srinath, B B Reeve, R T Croyle, R Ballard-Barbash. Am J Med Genet A 2003
133
19

Dopamine receptor DRD2 genotype and smoking cessation outcome following treatment with bupropion SR.
G E Swan, A M Valdes, H Z Ring, T V Khroyan, L M Jack, C C Ton, S J Curry, T McAfee. Pharmacogenomics J 2005
83
19

Association of catechol-O-methyltransferase with smoking cessation in two independent studies of women.
Susan Colilla, Caryn Lerman, Peter G Shields, Christopher Jepson, Margaret Rukstalis, Jesse Berlin, Angela DeMichele, Greta Bunin, Brian L Strom, Timothy R Rebbeck. Pharmacogenet Genomics 2005
69
19

The heritability of failed smoking cessation and nicotine withdrawal in twins who smoked and attempted to quit.
Hong Xian, Jeffrey F Scherrer, Pamela A F Madden, Michael J Lyons, Ming Tsuang, William R True, Seth A Eisen. Nicotine Tob Res 2003
92
19

Catechol-O-methyltransferase (COMT) gene variants predict response to bupropion therapy for tobacco dependence.
Wade H Berrettini, E Paul Wileyto, Leonard Epstein, Stephanie Restine, Larry Hawk, Peter Shields, Ray Niaura, Caryn Lerman. Biol Psychiatry 2007
59
19

Genetics and smoking cessation improving outcomes in smokers at risk.
Caryn E Lerman, Robert A Schnoll, Marcus R Munafò. Am J Prev Med 2007
65
19

A genetic association for cigarette smoking behavior.
S Z Sabol, M L Nelson, C Fisher, L Gunzerath, C L Brody, S Hu, L A Sirota, S E Marcus, B D Greenberg, F R Lucas,[...]. Health Psychol 1999
198
16

Bupropion and 4-OH-bupropion pharmacokinetics in relation to genetic polymorphisms in CYP2B6.
Julia Kirchheiner, Christian Klein, Ingolf Meineke, Johanna Sasse, Ulrich M Zanger, Thomas E Mürdter, Ivar Roots, Jürgen Brockmöller. Pharmacogenetics 2003
184
16

A controlled trial of sustained-release bupropion, a nicotine patch, or both for smoking cessation.
D E Jorenby, S J Leischow, M A Nides, S I Rennard, J A Johnston, A R Hughes, S S Smith, M L Muramoto, D M Daughton, K Doan,[...]. N Engl J Med 1999
16

Smoking, alcoholism and genetic polymorphisms alter CYP2B6 levels in human brain.
Sharon Miksys, Caryn Lerman, Peter G Shields, Deborah C Mash, Rachel F Tyndale. Neuropharmacology 2003
153
16

Bupropion: a review of its mechanism of antidepressant activity.
J A Ascher, J O Cole, J N Colin, J P Feighner, R M Ferris, H C Fibiger, R N Golden, P Martin, W Z Potter, E Richelson. J Clin Psychiatry 1995
548
16

Dopamine D4 receptors and the risk of cigarette smoking in African-Americans and Caucasians.
P G Shields, C Lerman, J Audrain, E D Bowman, D Main, N R Boyd, N E Caporaso. Cancer Epidemiol Biomarkers Prev 1998
117
16

A vision for the future of genomics research.
Francis S Collins, Eric D Green, Alan E Guttmacher, Mark S Guyer. Nature 2003
16

Treating tobacco dependence: state of the science and new directions.
Caryn Lerman, Freda Patterson, Wade Berrettini. J Clin Oncol 2005
49
16


The role of CYP2A6 in the emergence of nicotine dependence in adolescents.
Janet Audrain-McGovern, Nael Al Koudsi, Daniel Rodriguez, E Paul Wileyto, Peter G Shields, Rachel F Tyndale. Pediatrics 2007
89
16

Lack of association of 5-HTTLPR genotype with smoking cessation in a nicotine replacement therapy randomized trial.
Marcus R Munafò, Elaine C Johnstone, E Paul Wileyto, Peter G Shields, Katherine M Elliot, Caryn Lerman. Cancer Epidemiol Biomarkers Prev 2006
43
16

Current and emerging pharmacotherapies for treating tobacco dependence.
Robert A Schnoll, Caryn Lerman. Expert Opin Emerg Drugs 2006
76
16


Novel genes identified in a high-density genome wide association study for nicotine dependence.
Laura Jean Bierut, Pamela A F Madden, Naomi Breslau, Eric O Johnson, Dorothy Hatsukami, Ovide F Pomerleau, Gary E Swan, Joni Rutter, Sarah Bertelsen, Louis Fox,[...]. Hum Mol Genet 2007
456
16

The serotonin transporter 5-HTTLPR polymorphism and treatment response to nicotine patch: follow-up of a randomized controlled trial.
Sean P David, Marcus R Munafò, Michael F G Murphy, Robert T Walton, Elaine C Johnstone. Nicotine Tob Res 2007
43
16

A functional polymorphism of the mu-opioid receptor gene is associated with naltrexone response in alcohol-dependent patients.
David W Oslin, Wade Berrettini, Henry R Kranzler, Helen Pettinati, Joel Gelernter, Joseph R Volpicelli, Charles P O'Brien. Neuropsychopharmacology 2003
437
12

Bupropion is a nicotinic antagonist.
J E Slemmer, B R Martin, M I Damaj. J Pharmacol Exp Ther 2000
377
12


Mediating mechanisms for the impact of bupropion in smoking cessation treatment.
Caryn Lerman, David Roth, Vyga Kaufmann, Janet Audrain, Larry Hawk, Aiyi Liu, Ray Niaura, Leonard Epstein. Drug Alcohol Depend 2002
127
12

Single-nucleotide polymorphism in the human mu opioid receptor gene alters beta-endorphin binding and activity: possible implications for opiate addiction.
C Bond, K S LaForge, M Tian, D Melia, S Zhang, L Borg, J Gong, J Schluger, J A Strong, S M Leal,[...]. Proc Natl Acad Sci U S A 1998
812
12

Changes in food reward following smoking cessation: a pharmacogenetic investigation.
Caryn Lerman, Wade Berrettini, Angela Pinto, Freda Patterson, Susan Crystal-Mansour, E Paul Wileyto, Stephanie L Restine, Debra G B Leonard, Peter G Shields, Leonard H Epstein. Psychopharmacology (Berl) 2004
42
12

The effectiveness of the nicotine patch for smoking cessation. A meta-analysis.
M C Fiore, S S Smith, D E Jorenby, T B Baker. JAMA 1994
437
12

Allelic association of the D2 dopamine receptor gene with receptor-binding characteristics in alcoholism.
E P Noble, K Blum, T Ritchie, A Montgomery, P J Sheridan. Arch Gen Psychiatry 1991
519
12


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.